Eventide Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Eventide Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $11.6 Million - $13.8 Million	-45,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $9.09 Million - $11.3 Million	45,500 New	45,500 $10.8 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $4.28 Million - $4.95 Million	-26,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $32.3 Million - $38.4 Million	-197,000 Reduced 88.34%	26,000 $4.78 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $13.7 Million - $17.3 Million	-90,000 Reduced 28.75%	223,000 $37 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $11.7 Million - $13.5 Million	70,000 Added 28.81%	313,000 $60.3 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $9.55 Million - $11.2 Million	63,000 Added 35.0%	243,000 $39.6 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $26.7 Million - $29.2 Million	180,000	180,000 $27.4 Million

1,708

220M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.